Author Topic: FDA rushing risky drugs to marketplace (MedPage Today)  (Read 112 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9816
  • MS diagnosed 1980
  • Location: Pacific Northwest
FDA rushing risky drugs to marketplace (MedPage Today)
« on: July 03, 2018, 09:12:46 pm »

The rather long article here, "FDA rushing risky drugs to marketplace," doesn't mention MS drugs but provides information about the current tendency to fast-track some drugs, possibly before the drug has been established as safe. 

From MedPage Today (July 3, 2018).


https://www.medpagetoday.com/washington-watch/fdageneral/73842?xid=nl_mpt_investigative2018-07-03&eun=g345846d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=InvestigateMD_070318&utm_term=Pop%20Medicine
« Last Edit: July 03, 2018, 09:53:08 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
193 Views
Last post March 22, 2017, 10:22:27 am
by agate
0 Replies
106 Views
Last post June 07, 2018, 10:11:10 am
by agate
0 Replies
101 Views
Last post October 14, 2018, 04:04:04 pm
by agate
0 Replies
40 Views
Last post November 26, 2020, 08:23:35 am
by agate
0 Replies
24 Views
Last post January 07, 2022, 09:48:12 am
by agate